Blood cell composition accounts for up to 53% of variation in DNA methylation age, with distinct influences on epigenetic clock measures and biological processes.
- Open access
Moving in Genome Medicine.
Rebuilt
Blood cell composition accounts for up to 53% of variation in DNA methylation age, with distinct influences on epigenetic clock measures and biological processes.
Newest first · last 60 days
ALKBH5-driven epitranscriptomic changes in cancer-associated fibroblasts promote pancreatic cancer metastasis independently of primary tumor growth.
Blood cell composition accounts for up to 53% of variation in DNA methylation age, with distinct influences on epigenetic clock measures and biological processes.
Genetic variation and misalignment of the circadian clock significantly influence human health, disease risk, and treatment outcomes, highlighting the importance of temporal biology.
Ageing results from the progressive loss of cellular identity constraints, with 90% of age-related DNA methylation changes occurring at PRC2-bound regions in mammals.
Loss of KDM6A enhances oxidative phosphorylation across multiple tissues, revealing a conserved mechanism of tissue-level convergent evolution in cancer and development.
Nuclear OXCT1 reduces histone β-hydroxybutyrylation at MHC-I loci, decreasing immune gene transcription and impacting hepatocellular carcinoma response to immunotherapy.
Cryo-EM structures reveal a bifunctional TDM enzyme with a novel channeling pathway that guides formaldehyde to a remote tetrahydrofolate site, enhancing metabolic efficiency.
DOT1L regulates ncPRC1 complexes and H2AK119ub1 to sustain germinal center B cell identity in diffuse large B cell lymphoma, with 20 key gene targets identified.
ChromBPNet accurately predicts chromatin accessibility and regulatory variants at base resolution, outperforming larger models with a lightweight design across diverse assays and contexts.
Journals this month
Moving areas, week to 3 Oct 2026